Current UK guidelines for the detection of sickle cell disease (SSD) r
ecommend pre-operative screening of patients of African or Afro-Caribb
ean descent and of patients from the Middle East, South Italy, Greece
and India. These recommendations have considerable cost implications f
or the NHS We have undertaken a retrospective audit of the use of SSD
screening in our own institution. Between January 1987 and August 1992
, 1305 patients under 15 years of age (mean 3.8 years) underwent scree
ning for SSD. Surgical patients accounted for 1120 tests (85.8%). The
majority of patients tested were of Asian descent (n = 955; 73%); only
350 (27%) were of African or Afro-Caribbean descent. Only four patien
ts (0.3%) tested positive (all sickle cell trait); three of Afro-Carib
bean descent and one from Bahrain. We conclude that, in our population
, the incidence of HbS is low. Patients of African or Afro-Caribbean d
escent should continue to be tested but a selective policy may be indi
cated in other ethnic groups.